Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 89
Central Nervous System Drugs 66
Endocrine and Metabolic Disorders Drugs 55
Infusions and Injectables 33
Musculoskeletal Disorders Drugs 29
Drug Discovery 26
Surgical Procedures 24
Pharmaceuticals 20
Biopharmaceuticals 15
Prostate Cancer Drugs 13
Drug Delivery 13
Dermatology 13
Women's Health 12
Liver Cancer Drugs 10
Clinical Trials 10
Oncology 10
Neurology 9
Pancreatic Cancer Drugs 9
Thyroid Cancer Drugs 8
Biotechnology 7
Lung Cancer Drugs 7
Medical Devices 7
Healthcare Services 6
Immune Disorders Drugs 6
Breast Cancer Drugs 6
Genomics 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Company Reports 5
Kidney Cancer Drugs 5
Dermatological Drugs 5
Sexual and Reproductive Health Drugs 5
Urology and Nephrology 4
Ovarian Cancer Drugs 4
Brain Cancer Drugs 4
Enzymes 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Colon Cancer Drugs 3
Bladder Cancer Drugs 3
Managed Care 3
Over the Counter (OTC) Drugs 3
Gastroenterology 3
Urological Disorders Drugs 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Needles and Syringes 2
Hematology 2
Surgical Devices 2
Hematological Drugs 2
Biosimilars and Biosuperiors 2
Laboratory Equipment 2
Pediatrics 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Healthcare 1
Transdermal and Transmucosal Drug Delivery 1
Nuclear Medicine and Radiopharmacology 1
Skin Cancer Drugs 1
Other Healthcare Facilities 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Endocrinology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

469 Results (Page 8 of 24)
- Relevance
  Sort by

Carcinoid Syndrome Diarrhea Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€3973EUR$4,500USD£3,448GBP

Vinca Alkaloid Compounds Market - Global Forecast 2025-2030

 Report
August 2025
199 Pages
Global

From

€3130EUR$3,545USD£2,716GBP

€3478EUR$3,939USD£3,018GBP

Gastrointestinal Stromal Tumors Therapeutics Market 2025-2029

 Report
June 2025
214 Pages
Global

From

€2207EUR$2,500USD£1,916GBP

VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030

 Report
August 2025
185 Pages
Global

From

€3130EUR$3,545USD£2,716GBP

€3478EUR$3,939USD£3,018GBP

Botox Injection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
71 Pages
Global

From

€3500EUR$4,246USD£3,144GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

PDGFR Inhibitor Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3130EUR$3,545USD£2,716GBP

€3478EUR$3,939USD£3,018GBP

Botulinum Toxin Filler Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
February 2023
89 Pages
Global

From

€3500EUR$4,246USD£3,144GBP

Botulinum Toxin Injection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
February 2023
87 Pages
Global

From

€3500EUR$4,246USD£3,144GBP

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

 Report
June 2024
64 Pages
Global

€9780EUR$11,464USD£8,200GBP

Endometriosis Treatment Market Report and Forecast 2024-2032

 Report
July 2024
200 Pages
Global

From

€4370EUR$4,949USD£3,792GBP

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups

 Report
May 2024
50 Pages
United States

€9780EUR$11,464USD£8,200GBP

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
1079 Pages
Global

From

€2207EUR$2,500USD£1,916GBP

Ethical Pharmaceuticals Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,440GBP

Controlled Substance Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,440GBP

Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
August 2022
168 Pages
Global

From

€2207EUR$2,500USD£1,916GBP

Interleukin Inhibitors Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3965EUR$4,490USD£3,440GBP

Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
157 Pages
Global

From

€1766EUR$2,000USD£1,532GBP

Bromhidrosis Disease Treatment Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3130EUR$3,545USD£2,716GBP

€3478EUR$3,939USD£3,018GBP

Acromegaly Treatment Market - Global Forecast 2025-2030

 Report
August 2025
180 Pages
Global

From

€3130EUR$3,545USD£2,716GBP

€3478EUR$3,939USD£3,018GBP

Carglumic Acid Market - Global Forecast 2025-2030

 Report
August 2025
199 Pages
Global

From

€3130EUR$3,545USD£2,716GBP

€3478EUR$3,939USD£3,018GBP

469 Results (Page 8 of 24)
- 1
- 6
- 7
- 8
- 9
- 10

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.